Thelansis

 Juvenile idiopathic arthritis (JIA), also known as juvenile rheumatoid arthritis, refers to a group of conditions involving joint inflammation (arthritis) that first appear before age 16. The term "idiopathic" indicates that the specific cause of the disorder is unknown. Researchers have identified changes in several genes that may influence the risk of developing juvenile idiopathic arthritis. Some of these genes belong to a family of genes that provide instructions for making a group of related proteins called the human leukocyte antigen (HLA) complex. ·        The incidence of Juvenile idiopathic arthritis (JIA) in North America and Europe is estimated to be 4 to 16 in 10,000 children   Thelansis’s “Juvenile Idiopathic Arthritis (JIA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, c...

 Juvenile idiopathic arthritis (JIA), also known as juvenile rheumatoid arthritis, refers to a group of conditions involving joint inflammation (arthritis) that first appear before age 16. The term "idiopathic" indicates that the specific cause of the disorder is unknown. Researchers have identified changes in several genes that may influence the risk of developing juvenile idiopathic arthritis. Some of these genes belong to a family of genes that provide instructions for making a group of related proteins called the human leukocyte antigen (HLA) complex. ·        The incidence of Juvenile idiopathic arthritis (JIA) in North America and Europe is estimated to be 4 to 16 in 10,000 children. Thelansis’s “Juvenile Idiopathic Arthritis (JIA) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical...

  Juvenile idiopathic arthritis (JIA) also known as juvenile rheumatoid arthritis refers to a group of conditions involving joint inflammation (arthritis) that first appears before the age of 16.   Etiology- The term "idiopathic" indicates that the specific cause of the disorder is unknown. Researchers have identified changes in several genes that may influence the risk of developing juvenile idiopathic arthritis. Some of these genes belong to a family of genes that provide instructions for making a group of related proteins called the human leukocyte antigen (HLA) complex.   Epidemiology- The incidence of juvenile idiopathic arthritis in North America and Europe is estimated to be 4 to 16 in 10,000 children. Approximately 294,000, children in the United States are affected.   The competitive landscape of Juvenile Idiopathic Arthritis (JIA) includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or revi...